Relationship between accepted response categories and sFLCr normalization.

Figshare2018-09-07 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Relationship_between_accepted_response_categories_and_sFLCr_normalization_/7061465 数据链接链接失效反馈

官方服务：

资源简介：

Relationship between accepted response categories and sFLCr normalization.

创建时间：

2018-09-07

Overall and complete response rates as potential surrogates for overall survival in relapsed/refractory multiple myeloma Suppl data

多发性骨髓瘤疗效评估

肿瘤临床试验替代终点

Overall and complete response rates as potential surrogates for overall survival in relapsed/refractory multiple myeloma Suppl data

Figshare2023-05-12 更新30

Measurement Error in Real-World Comparative Effectiveness Studies of Progression Free Survival in Multiple Myeloma

真实世界研究

多发性骨髓瘤疗效评估

Randomised-controlled trials (RCTs) are research studies used to determine how effective a new treatment is in comparison to a different, more established treatment. In an RCT, patients are randomly a

DataCite Commons2025-06-23 更新10

Number of responders (≥PR) and non-responders (

多发性骨髓瘤疗效评估

真实世界数据算法验证

Real-world data (RWD) are important for understanding the treatment course and response patterns of patients with multiple myeloma. This exploratory pilot study establishes a way to reliably assess re

NIAID Data Ecosystem00

DataSheet_1_Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?.pdf

多发性骨髓瘤疗效评估

血清游离轻链检测

Serum and urine protein electrophoresis and immunofixation are the preferred techniques for monitoring monoclonal proteins and evaluating treatment response in multiple myeloma (MM) patients with meas

NIAID Data Ecosystem20

Analysis of the differences in overall response rate, ≥VGPR and ≥CR in the intervention and placebo arms of the BELLINI trial by IRC and the dR algorithm using 50% of all available laboratory measurements.

多发性骨髓瘤疗效评估

临床数据分析

Figshare2023-05-11 更新00